These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12944898)

  • 1. Evidence-based emergency medicine/systematic review abstract. Antiplatelet agents for acute ischemic stroke.
    Stead LG
    Ann Emerg Med; 2003 Sep; 42(3):423-5. PubMed ID: 12944898
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence-based emergency medicine/systematic review abstract. Corticosteroid treatment for acute ischemic stroke.
    Stead LG; Rowe BH
    Ann Emerg Med; 2003 Jul; 42(1):150-2. PubMed ID: 12827134
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies.
    Luo S; Zhuang M; Zeng W; Tao J
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based emergency medicine/systematic review abstract. Use of anticoagulants in acute ischemic stroke.
    Stead LG
    Ann Emerg Med; 2004 Nov; 44(5):540-2. PubMed ID: 15520717
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence-based emergency medicine/systematic review abstract. Role of abciximab in the management of acute ischemic stroke.
    Stead LG; Vaidyanathan L
    Ann Emerg Med; 2009 Mar; 53(3):392-4. PubMed ID: 19231667
    [No Abstract]   [Full Text] [Related]  

  • 6. Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta-analysis of cohort studies and randomized controlled trials.
    Pan X; Zhu Y; Zheng D; Liu Y; Yu F; Yang J
    Int J Stroke; 2015 Apr; 10(3):317-23. PubMed ID: 25545076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Antiplatelet Therapy of Clopidogrel and Aspirin in Secondary Prevention of Ischemic Stroke: Evidence and Indications.
    Su Y; Cheng X; Dong Q
    CNS Neurosci Ther; 2015 Nov; 21(11):870-6. PubMed ID: 26122554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights in antiplatelet therapy for patients with ischemic stroke.
    Chaturvedi S; Bhattacharya P
    Neurologist; 2011 Sep; 17(5):255-62. PubMed ID: 21881467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Stroke; 2017 Sep; 48(9):2610-2613. PubMed ID: 28701574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination oral antiplatelet therapy may increase the risk of hemorrhagic complications in patients with acute ischemic stroke caused by large artery disease.
    Itabashi R; Mori E; Furui E; Sato S; Yazawa Y; Fujiwara S
    Thromb Res; 2011 Dec; 128(6):541-6. PubMed ID: 21741075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy in management of transient ischemic attack: overview and evidence-based rationale.
    Ovbiagele B
    J Emerg Med; 2008 May; 34(4):389-96. PubMed ID: 18207691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
    Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
    Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations and treatment strategies for the management of acute ischemic stroke.
    Segura T; Calleja S; Jordan J
    Expert Opin Pharmacother; 2008 May; 9(7):1071-85. PubMed ID: 18422467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
    Davis KA; Miyares MA; Dietrich E
    Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy of stroke].
    Bereczki D
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):7-13. PubMed ID: 19731813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does prior antiplatelet treatment improve functional outcome after intra-arterial treatment for acute ischemic stroke?
    Mulder MJ; Berkhemer OA; Fransen PS; van den Berg LA; Lingsma HF; den Hertog HM; Staals J; Jenniskens SF; van Oostenbrugge RJ; van Zwam WH; Majoie CB; van der Lugt A; Dippel DW;
    Int J Stroke; 2017 Jun; 12(4):368-376. PubMed ID: 27807281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after stroke thrombolysis according to prior antiplatelet use.
    Meseguer E; Labreuche J; Guidoux C; Lavallée PC; Cabrejo L; Sirimarco G; Valcarcel JG; Klein IF; Amarenco P; Mazighi M
    Int J Stroke; 2015 Feb; 10(2):163-9. PubMed ID: 25487908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.